Halcion and Hearing loss - a phase IV clinical study of FDA data

Summary:

Hearing loss is reported as a side effect among people who take Halcion (triazolam), especially for people who are male, 60+ old, also take Fosamax, and have Gynecomastia.

The phase IV clinical study analyzes which people have Hearing loss when taking Halcion. It is created by eHealthMe based on reports of 8,113 people who have side effects when taking Halcion from the FDA, and is updated regularly.

What is Halcion?

Halcion has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 8,268 Halcion users. Check the latest studies of Halcion.

What is Hearing loss?

Hearing loss is found to be associated with 1,353 drugs and 2,378 conditions by eHealthMe. Check the latest studies of Hearing loss.

On Jul, 13, 2026

8,113 people reported to have side effects when taking Halcion.
Among them, 15 people (0.18%) have Hearing loss.

Among these 15 people:

What is the gender of people who have Hearing loss when taking Halcion? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Hearing loss when taking Halcion? *

What are other drugs people take besides Halcion? *

What are other side effects people have besides Hearing loss? *

Indigestion: 8 people, 53.33%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 8 people, 53.33%
Osteoporosis (bones weak and more likely to break): 8 people, 53.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 53.33%
Stress And Anxiety: 8 people, 53.33%
Swallowing Difficulty: 8 people, 53.33%
Pain: 8 people, 53.33%
Sinusitis (inflammation of sinus): 7 people, 46.67%
Fever: 7 people, 46.67%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 46.67%

What are the existing conditions these people have? *

Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 6 people, 40.00%
Gynecomastia (enlargement of the gland tissue of the male breast): 6 people, 40.00%
Osteopenia (a condition where bone mineral density is lower than normal): 4 people, 26.67%
Pain: 3 people, 20.00%
Postpartum Depression (depression suffered by a mother following childbirth): 2 people, 13.33%
Neuralgia (pain in one or more nerves): 2 people, 13.33%
High Blood Pressure: 1 person, 6.67%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 6.67%
Gastritis (inflammation of stomach): 1 person, 6.67%
Breakthrough Pain: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Halcion and have Hearing loss?

- Check whether Hearing loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Halcion:

Halcion (8,268 reports)

Hearing loss treatments and more:

Hearing loss (30,352 reports)

Browse all side effects of Halcion:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hearing loss:

Hearing loss (1,353 drugs)

Browse all the conditions that are associated with Hearing loss:

Hearing loss (2,378 conditions)

Related publications that referenced our studies

Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on triazolam (the active ingredients of Halcion) and Halcion (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.